Vor Biopharma Inc (VOR)
1.76
-0.04
(-2.22%)
USD |
NASDAQ |
May 06, 16:00
1.75
-0.01
(-0.57%)
After-Hours: 20:00
Vor Biopharma Cash from Operations (TTM): -100.29M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.29M |
| September 30, 2023 | -94.61M |
| June 30, 2023 | -85.62M |
| March 31, 2023 | -86.51M |
| December 31, 2022 | -85.14M |
| September 30, 2022 | -84.38M |
| June 30, 2022 | -82.83M |
| Date | Value |
|---|---|
| March 31, 2022 | -74.40M |
| December 31, 2021 | -69.14M |
| September 30, 2021 | -65.19M |
| June 30, 2021 | -56.09M |
| March 31, 2021 | -47.86M |
| December 31, 2020 | -36.29M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-100.29M
Minimum
Dec 2023
-36.29M
Maximum
Dec 2020
-74.49M
Average
-82.83M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| Masimo Corp | 94.10M |
| AnaptysBio Inc | -120.80M |
| Apellis Pharmaceuticals Inc | -594.74M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |